The Points program on its own produces modest, steady weight loss for people who stick with it, mostly by adding structure and awareness to eating
This information does not substitute for professional diagnosis and treatment
Pharmaceutical giants such as Novo Nordisk and Eli Lilly are pouring billions into production expansion to meet this surge
It's important to note that Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though they may be used off-label for weight loss
Completing either task gave them a chance to win money, and they could win more money by doing "hard" tasks than "easy" ones
Notably, about one in four of these patients did not carry a type 2 diabetes diagnosis , suggesting that a substantial portion of GLP-1 use is being driven by weight loss and other emerging indications outside of diabetes care (Figure 2)